event about "globale Studie"

20 October 2025, 13:13

A global study shows that 77% of patients observed a reduction in tumors with zongertinib, an innovative treatment for HER2 lung cancer.

Sources

Health

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

app preview

google play badge